Drug Costs

Line Art 1
Line Art 2
Line Art 3
Line Art 4

2024 round-up: Prescryptive in the news

The best soundbites from our experienced thought leaders.

Every question you have about paying in cash for prescriptions, answered 

With prescription prices going up, it’s reasonable to look for a variety of ways to pay for your…

As Seen In: SHRM

Health Care Costs Are Frightening Employers—but These Strategies Can Make Them Less Scary

According to SHRM, employers have reason to be anxious: “New projections find that inflation, GLP-1 drugs, and catastrophic…

As Seen In: TODAY Show

Here’s what to know before shopping at online pharmacies

The TODAY Show shared tips on what precautions healthcare consumers should take when shopping at online pharmacies –…

As Seen In: CNBC

Pharmacy deserts are appearing across U.S. as Rite Aid, Walgreens, CVS drug store closures spread

In this wide-ranging piece, CNBC explores the phenomenon of pharmacy deserts. “Decreased reimbursements are putting the squeeze on…

Digital prescriptions get the patient back in the prescription workflow to help drive down costs 

A recent study found that one in five adults said they haven’t filled a prescription because of the…

As Seen In: BenefitsPRO

Pharmacy benefit managers, version 2.0 (post J&J lawsuit)

In this extensive and thoughtful Q&A in BenefitsPRO, our SVP, Payer Solutions, Rae McMahan discusses the current state…

As Seen In: TODAY Show

How to save on prescription medications

The cost of prescriptions may be going up, but there are ways to find savings. Kelcey Blair, SVP,…

6 ways to supercharge your PBM search

With the 2025 RFP season here, now is the perfect time to reflect on the impact and effectiveness…

As Seen In: Pharma News Intelligence

Understanding the widespread impacts of pharmacy deserts

Pharmacy deserts, perpetuated by multiple factors, have significant implications for patient care and public health. See how Paige…

As Seen In: Medical Economics

Change is coming to old pharmacy benefits models – here’s what it can mean for healthcare

The legacy PBM model is no longer sustainable. But the good news is that pharma and other healthcare…

REPORT: Employer attitudes on GLP-1s, including coverage, costs, and outcomes

A recent report by Pharmaceutical Strategies Group (PSG), sponsored by Prescryptive, spotlighted red hot GLP-1s and how employers…